 Hemostatic disorders are common and potentially fatal complications in patients undergoing hematopoietic stem-cell transplantation HSCT. Limited data exist on early diagnosis and prevention of these complications. The investigators undertook this prospective study to determine the incidence, predictor factors, specific pathogenesis, management and survival specially for patients with thrombotic and bleeding complication to better improve outcomes. 